Cara Therapeutics | CARA - Bruttoergebnis Vom Umsatz





Bruttoergebnis Vom Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 243.27M 14.49M 2026-03
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cassava Sciences USD -3.96M 1.16M 2025-09
Chugai Pharma JPY 258.74B 25.81B 2025-12
Cipla INR 39.1B 2.54B 2026-03
Clal Biotechnology ILS -857K 1.42M 2022-06
Compugen USD 352K 63.44M 2026-03
CSL USD 4.46B 2.71B 2025-12
Grifols EUR 766.49M 39.74M 2024-12
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
J&J USD 17.24B 642M 2026-03
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Pacira USD 126.64M 15.61M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
RedHill Biopharma USD 584K 0 2024-06
Supernus Pharmaceuticals USD 129.36M 34.68M 2026-03
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12